3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does 3D Global Biotech Inc. (6808) operate in?
3D Global Biotech Inc. belongs to the Other sector and operates in the Biotechnology industry.
What is 3D Global Biotech Inc. (6808) current stock price?
As of the latest data, 3D Global Biotech Inc. stock price is NT$35.95, with a previous close of NT$35.95.
What is 3D Global Biotech Inc. (6808) current market capitalization?
3D Global Biotech Inc. market cap is approximately 2.77 billion.
What is 3D Global Biotech Inc. (6808) Earnings Per Share (EPS)?
The trailing EPS is NT$0.84.
What is 3D Global Biotech Inc. (6808) Price-to-Earnings (P/E) ratio?
3D Global Biotech Inc. current P/E ratio is 42.8.
Does 3D Global Biotech Inc. (6808) pay dividends?
Yes. 3D Global Biotech Inc. pays annual dividends with an annualized yield of 0.37% and an estimated annual payout of NT$0.13 per share.
When is the next ex-dividend date for 3D Global Biotech Inc. (6808)?
The next ex-dividend date is scheduled for July 16, 2027.
What is 3D Global Biotech Inc. (6808) beta (volatility) score?
3D Global Biotech Inc. has a beta of 0.205, indicating lower volatility than the overall market.